Stacy Centeno
Nurse Practitioner · Sarasota, FLNPI 1508215450
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $54,856 of the $72,530 with a category attached, or 75.6%. 16 manufacturers reported payments, led by Dexcom, Inc. at 47.9% of the total. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $412.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$35K
- Novo Nordisk$28K
- Abbott$7K
- Bayer$349
- Amgen$347
- Xeris Pharmaceuticals, Inc.$323
- plus $1K from 10 others
What the payments were for
- Consulting fees$4,4176%
- Speaking & faculty fees$54,85676%
- Travel & lodging$7,33010%
- Food & beverage$5,8478%
- Education$200%
- Gifts$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 67 | $34,747 |
| Novo Nordisk | 41 | $28,449 |
| Abbott | 22 | $7,015 |
| Bayer | 3 | $349 |
| Amgen | 6 | $347 |
| Xeris Pharmaceuticals, Inc. | 9 | $323 |
| BETA Bionics, Inc. | 5 | $239 |
| Tandem Diabetes Care, Inc. | 4 | $211 |
| Insulet Corporation | 4 | $192 |
| Sanofi-aventis U.S. LLC | 3 | $176 |
| Lilly USA, LLC | 3 | $129 |
| Sequel Med Tech, LLC | 1 | $99 |
| Radius Health, Inc. | 1 | $95 |
| Mannkind Corporation | 3 | $94 |
| Medtronic | 3 | $45 |
| Ascendis Pharma Endocrinology Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$22,247
- DEXCOM G6 TRANSMITTER$19,257
- DEXCOM G7 GSS (161)$14,547
- FREESTYLE LIBRE 3$6,652
- DEXCOM STELO GLUCOSE BIOSENSOR$6,609
- Ozempic$4,418
- iLet Bionic Pancreas$368
- Kerendia$250
- EVENITY$128
- Omnipod$101
How this compares
$72,530 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 916 | $1,192,325 |
| OzempicSemaglutide | 626 | $958,097 |
| Tresiba Flextouch U-200Insulin Degludec | 367 | $514,006 |
| JardianceEmpagliflozin | 184 | $287,104 |
| RybelsusSemaglutide | 138 | $212,095 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 109 | $171,991 |
| TrulicityDulaglutide | 124 | $171,003 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 93 | $165,288 |
| FarxigaDapagliflozin Propanediol | 112 | $134,518 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 60 | $131,307 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 98 | $101,362 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 67 | $99,959 |
| Tresiba Flextouch U-100Insulin Degludec | 87 | $60,818 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 57 | $53,049 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 31 | $53,027 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $129 | $1,396,7451,098 claims |
| Novo NordiskOzempic, Rybelsus, Xultophy 100-3.6, Fiasp, Novolog | $28,449 | $1,352,799898 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $176 | $44,78748 claims |
| BayerKerendia | $349 | $32,86326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Sarasota
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.